Full Spectrum Biotechnology Consulting provides strategic business and technical consulting to venture capital firms and startup biotechnology companies. Our focus is to create successful companies by aligning technologies and markets. We recognize that success comes from the productive interaction of companies, resources, and customers, and we work with our clients to achieve it. In addition, we provide training, reports and due diligence services to a variety of venture capital firms.

Biotechnology
Our services cover all aspects of biotechnology. The group has consulted for companies in all aspects of the process from gene sequence to cells, cell culture, fermentation, protein production and purification, target identification, target selection, structure function analysis of proteins, methods for lead compound creation and selection, structure activity analyses for lead compounds, microfluidics and catalysis. We have core expertise in computing, both hardware and software and specialize in computing solutions that expedite chemistry or biotechnology. We actively seek new technologies and work assiduously to create commercial realizations of novel breakthroughs. Intellectual property creation and management is often a key factor in early success for biotechnology companies and we work actively with our clients to create, license, and protect it.

Startup Companies
Strategic business consulting for new ventures is our core business. We strive to offer strategic business advice that couples expert business knowledge with superior technical understanding. To maximize the probability of success, we find high value markets for entrepreneur and work with them to close win-win deals. We work with all aspects of startup creation from commercialization plans to business plans, to team building, IP portfolio management, and actively participate in the funding process. Our goal is to create value for our clients. As needed by our clients, we develop presentations and pitches, participate in customer and investor presentations, as well as licensing and business negotiations. When needed, we can take active roles as interim management.

Public Companies
We provide retained services for Fortune 500 clients. These include position papers, identifying strategic assets, technology portfolios and plans to commercialize these technologies independent of the parent company.

Venture Capital
For our venture clients, we specialize in depth analyses of startup companies. We evaluate the company as a whole, seeking strengths, weakness, opportunities, and suggest execution strategies for success. Our specialty is providing forecasts for the optimal applications of novel technologies and assessments of markets for those technologies. We also prepare position papers and seminars for partners.

Peter David
Peter David is the founder of Full Spectrum Biotechnology Consulting. After solving the yeast RNA pol II x-ray crystal structure at Stanford University, he co-founded a molecular diagnostics firm with Jonathan Cool, now at Foundation Medical Partners. Subsequently, he consulted to help start Syrrx, a technology intensive drug discovery platform company and worked with them for two and half years. He serves as an advisor to venture capital firms. He is an active entrepreneur and consultant to a number of biotechnology companies and a cofounder of BioE2E, a forum for biotechnology entrepreneurs. He received his masters and Ph.D. in Physical Chemistry from Harvard University, where he worked with Nobel laureate, William N. Lipscomb. He is an alumnus of Oberlin College. He has over twenty years of experience in biotechnology and almost thirty years experience in applied computing, both high performance and dedicated computing.